Treatment-Related Upper Limb Morbidity 1 Year after Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection for Stage I or II Breast Cancer

J.S. Rietman,Pieter U. Dijkstra,Joannes Geertzen,Paul Baas,J. de Vries,W.V. Dolsma,Johan Groothoff,W.H. Eisma,H. J. Hoekstra

Treatment-Related Upper Limb Morbidity 1 Year after Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection for Stage I or II Breast Cancer

2004

J.S. Rietman
Pieter U. Dijkstra
Joannes Geertzen
Paul Baas
J. de Vries
W.V. Dolsma
Johan Groothoff
W.H. Eisma
H. J. Hoekstra

Background: In a prospective study, upper limb morbidity and perceived disability/activities of daily life (ADLs) were assessed before and 1 year after sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND).

Keywords:

Upper limb
Breast cancer
Mastectomy
Axillary Lymph Node Dissection
Pathology
Biopsy
Sentinel lymph node
General surgery
Lymphadenectomy
Surgery
Stage (cooking)
Medicine
Axilla
Range of motion
Grip strength
Forearm

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

107

Citations